The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(4-((6-Hydroxypyrimidin-4-yl)oxy)phenyl)-3-(3-(trifluoromethyl)phenyl)urea ID: ALA4873277
PubChem CID: 164623580
Max Phase: Preclinical
Molecular Formula: C18H13F3N4O3
Molecular Weight: 390.32
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1ccc(Oc2cc(O)ncn2)cc1)Nc1cccc(C(F)(F)F)c1
Standard InChI: InChI=1S/C18H13F3N4O3/c19-18(20,21)11-2-1-3-13(8-11)25-17(27)24-12-4-6-14(7-5-12)28-16-9-15(26)22-10-23-16/h1-10H,(H,22,23,26)(H2,24,25,27)
Standard InChI Key: SALXPUHKMSBHEK-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
10.6895 -28.9938 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.2851 -29.7037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1021 -29.6990 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.0882 -28.5191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0870 -29.3386 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5019 -28.5155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7933 -28.1102 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2081 -28.1043 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9173 -28.5102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9171 -29.3250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6255 -29.7309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3326 -29.3196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3269 -28.4982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6179 -28.0960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0424 -29.7246 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7480 -29.3124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4578 -29.7173 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7438 -28.4952 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.1634 -29.3051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8713 -29.7119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5764 -29.3004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5727 -28.4824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8579 -28.0776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1557 -28.4914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2898 -30.5229 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.5092 -29.3379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7943 -29.7454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7926 -30.5626 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 27 1 0
26 6 1 0
6 7 2 0
7 4 1 0
6 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
12 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
17 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
21 2 1 0
2 25 1 0
26 27 2 0
27 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 390.32Molecular Weight (Monoisotopic): 390.0940AlogP: 4.64#Rotatable Bonds: 4Polar Surface Area: 96.37Molecular Species: NEUTRALHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.16CX Basic pKa: 1.01CX LogP: 4.46CX LogD: 4.46Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.60Np Likeness Score: -1.55
References 1. Patterson JR, Graves AP, Stoy P, Cheung M, Desai TA, Fries H, Gatto GJ, Holt DA, Shewchuk L, Totoritis R, Wang L, Kallander LS.. (2021) Identification of Diarylurea Inhibitors of the Cardiac-Specific Kinase TNNI3K by Designing Selectivity Against VEGFR2, p38α, and B-Raf., 64 (21.0): [PMID:34699203 ] [10.1021/acs.jmedchem.1c00700 ]